Zobrazeno 1 - 10
of 284
pro vyhledávání: '"Dong Goo Kim"'
Autor:
Jisoo Lim, Eosu Kim, Hyun Jong Noh, Shinwon Kang, Benjamin U. Phillips, Dong Goo Kim, Timothy J. Bussey, Lisa Saksida, Christopher J. Heath, Chul Hoon Kim
Publikováno v:
Molecular Brain, Vol 12, Iss 1, Pp 1-13 (2019)
Abstract Genetic and pharmacological manipulations targeting metabotropic glutamate receptor 5 (mGluR5) affect performance in behavioural paradigms that depend on cognitive flexibility. Many of these studies involved exposing mice to highly stressful
Externí odkaz:
https://doaj.org/article/17f58c3c082c4681a072d3458b175a73
Publikováno v:
Asian Journal of Surgery, Vol 40, Iss 1, Pp 6-11 (2017)
Background: We introduced a modified laparoscopic technique, dual-incision laparoscopic adrenalectomy (DILA), using a newly designed multichannel trocar, and we evaluated its perioperative outcomes and operative costs and compared them to those of co
Externí odkaz:
https://doaj.org/article/a29b66fa9e6c403d9dd6221db0da12e9
Autor:
JooYeon Jhun, Seung Hoon Lee, Soon Kyu Lee, Hee Yeon Kim, Eun Sun Jung, Dong Goo Kim, JeongWon Choi, Si Hyun Bae, Seung Kew Yoon, Byung Ha Chung, Chul Woo Yang, Mi-La Cho, Jong Young Choi
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Recipients of liver transplantation (LT) require long-term immunosuppressive drug treatment, but lifelong immunosuppressive treatment has severe side effects. It is known that some LT recipients develop immune tolerance, and although the development
Externí odkaz:
https://doaj.org/article/e296f95caf8b4c53a48cc0705d6ebb2c
Autor:
Jong Hoon Lee, Yul Hee Cho, Seung Jee Ryu, Sin Seung Kim, Youn Hee Lee, In-Ae Jang, Bum Soon Choi, Jong Young Choi, Dong Goo Kim, Yeong Jin Choi, Chul Woo Yang, Byung Ha Chung
Publikováno v:
Kidney Research and Clinical Practice, Vol 32, Iss 4, Pp 153-157 (2013)
Background: Chronic kidney disease is a common complication after liver transplantation. In this study, we analyzed the results of kidney biopsy in liver transplantation recipients with renal impairment. Methods: Between 1999 and 2012, 544 liver tran
Externí odkaz:
https://doaj.org/article/a110a35d21c944b5bede4687f1c42f56
Autor:
Si Hyun Bae, Seung Kew Yoon, Jeong Won Jang, Dong Goo Kim, Gun Hyung Na, Il Young Park, Young Kyoung You, Sung Won Lee, Jong Young Choi, Ho Joong Choi, Hae Lim Lee
Publikováno v:
Liver Transplantation. 28:397-406
The anticancer effect of statins is drawing attention. However, it is unclear whether statin use reduces the risk of hepatocellular carcinoma (HCC) recurrence in patients who undergo liver transplantation (LT) for HCC. Consecutive patients who underw
Publikováno v:
Journal of Gastrointestinal Surgery. 25:1556-1558
Autor:
Seung Kew Yoon, Yoon Hee Jun, Dong Goo Kim, Ho Joong Choi, Sang Il Kim, Youn Jeong Kim, Y.K. You, Jong Young Choi
Publikováno v:
Transplantation Proceedings. 51:2766-2770
Background Enterococcus species are a common cause of bacteremia in liver transplant recipients. Vancomycin-resistant enterococci (VRE) have become an important cause of nosocomial infection. In this study, we analyzed the incidence, antibiotic resis
Autor:
Dong Goo Kim, Jung Ho Lee
Publikováno v:
Neuroreport
Drug use among adolescents continues to be an area of concern because of the possibility of long-lasting physical and mental changes. The aim of this study was to determine whether methamphetamine exposure during adolescence results in long-lasting n
Autor:
Sun-Bok Choi, Ho-Joon Song, Joon Yeon Shin, Sung-Joo Park, Myungsoo Joo, Myoung-Jin Kim, Il-Joo Jo, Dong-Uk Kim, Gi-Sang Bae, Dong-Goo Kim
Publikováno v:
International Immunopharmacology. 69:225-234
Heme oxygenase-1 (HO-1) has an anti-inflammatory action in acute pancreatitis (AP). However, its mechanism of action and natural compounds/drugs to induce HO-1 in pancreas are not well understood. In this study, we investigated the regulatory mechani
Autor:
Ho Jong Chun, Pil Soo Sung, Seung Kew Yoon, Hee Chul Nam, Jeong Won Jang, Dong Goo Kim, Jong Young Choi
Publikováno v:
Journal of Liver Cancer. 19:64-68
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The majority of patients with HCC are diagnosed at advanced disease stages with vascular invasion, where curative approaches are often not feasible. Currently, sorafenib is t